Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Strides Pharma Science Limited, is a listed public company incorporated on 28 June, 1990. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 218.37 cr and the total paid-up capital is INR 91.96 cr.
Strides Pharma Science Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 28.51% over the previous year. At the same time, it's book networth has increased by 1.42%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-6.29%
28.51%
-97.4%
1.42%
8.4%
3.42%
-1.8
1.44
-8.33
-5.15
3.93
0.02
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(16)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Trustee Services Limited
No. of Loans: 1
Total Amount : 1,994.6 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 250.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 150.0 cr
Catalyst Trusteeship Limited
No. of Loans: 1
Total Amount : 150.0 cr
Union Bank of India
No. of Loans: 1
Total Amount : 139.6 cr
IDBI Trusteeship Services Limited
No. of Loans: 3
Total Amount : 106.0 cr
RBL Bank Limited
No. of Loans: 2
Total Amount : 32.0 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 30.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 0.9 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Homi Rustam Khusrokhan | 00005085 | 8 years |
| Managing Director | Arun Kumar Pillai
Shareholder
|
00084845 | 21 years |
| Director | Ameet Pratapsinh Hariani | 00087866 | 1 years |
| Director | Subir Chakraborty | 00130864 | 1 years |
| Director | Aditya Arun Kumar | 06999081 | 1 years |
| Director | Kausalya Santhanam
Shareholder
|
06999168 | 5 years |
| CS | Manjula Ramamurthy
Shareholder
|
<HIDDEN> | 8 years |
| Kmp | Vikesh Kumar | <HIDDEN> | 1 years |
| CFO | Badree Komandur
Shareholder
|
<HIDDEN> | 1 years |
| Whole-time Director | Badree Komandur
Shareholder
|
07803242 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| THE ANGLO SCOTTISH EDUCATION SOCIETY |
Active
|
0.0 | 1 | Maharashtra |
| NEULAND LABORATORIES LTD. |
Active
|
12.8 Cr | 1 | Telangana |
| SKANRAY HEALTHCARE PRIVATE LIMITED |
Amalgamated
|
7.1 Cr | 1 | Karnataka |
| SEQUENT SCIENTIFIC LIMITED |
Amalgamated
|
4.3 Cr | 1 | Maharashtra |
| FRAXIS LIFE SCIENCES LIMITED |
Amalgamated
|
2.0 Cr | 1 | Maharashtra |
| ARCOLAB (INDIA) P.LTD. |
Amalgamated
|
1.0 L | 1 | Karnataka |
| ONESOURCE SPECIALTY PHARMA LIMITED |
Active
|
4.2 Cr | 1 | Karnataka |
| GRANDIX PHARMACEUTICALS LIMITED |
Amalgamated
|
46.4 L | 1 | Tamil Nadu |
| CHAYADEEP VENTURES LLP |
Active
|
1.0 L | 1 | Karnataka |
| AGNUS CAPITAL LLP |
Active
|
1.0 L | 1 | Karnataka |
| QUALICHEM REMEDIES LLP |
Active
|
1.0 L | 1 | Karnataka |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED |
Active
|
40.2 Cr | 2 | Maharashtra |
| QUADGEN WIRELESS SOLUTIONS PRIVATE LIMITED |
Active
|
156.2 Cr | 1 | Karnataka |
| APTECH LIMITED |
Active
|
58.0 Cr | 1 | Maharashtra |
| RADICLE INFORMATICS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| RAS RESORTS AND APART HOTELS LTD |
Active
|
4.0 Cr | 1 | Maharashtra |
| MAHINDRA HAPPINEST DEVELOPERS LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| TRUST AMC TRUSTEE PRIVATE LIMITED |
Active
|
50.0 L | 1 | Maharashtra |
| MAHINDRA WORLD CITY (JAIPUR) LIMITED |
Active
|
150.0 Cr | 1 | Rajasthan |
| HARIANI ADVISORY SERVICES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ENVISION COMPUTER CONSULTANCY PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| RADICLE INFORMATICS LLP |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ENVISION COMPUTER CONSULTANCY LLP |
Defunct
|
1.0 L | 1 | Maharashtra |
| HDFC ERGO GENERAL INSURANCE COMPANY LIMITED |
Active
|
723.7 Cr | 1 | Maharashtra |
| MAHINDRA LOGISTICS LIMITED |
Active
|
72.1 Cr | 1 | Maharashtra |
| MAHINDRA LIFESPACE DEVELOPERS LIMITED |
Active
|
155.1 Cr | 1 | Maharashtra |
| MAHINDRA INDUSTRIAL PARK CHENNAI LIMITED |
Active
|
170.0 Cr | 1 | Tamil Nadu |
| THE BENGAL CHAMBER OF COMMERCE AND INDUSTRY |
Active
|
0.0 | 1 | West Bengal |
| CHLORIDE INTERNATIONAL LIMITED |
Active
|
45.0 L | 1 | West Bengal |
| CHLORIDE ALLOYS INDIA LIMITED |
Amalgamated
|
25.0 Cr | 1 | West Bengal |
| EXIDE ENERGY PRIVATE LIMITED |
Amalgamated
|
168.5 Cr | 1 | West Bengal |
| KARUNA HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| STERIBROOKS PENEMS PRIVATE LIMITED |
Active
|
1.8 L | 1 | Karnataka |
| STERISCIENCE SPECIALTIES PRIVATE LIMITED |
Active
|
2.1 L | 1 | Maharashtra |
| KARUNA BUSINESS SOLUTIONS LLP |
Active
|
3.0 L | 1 | Karnataka |
| VELBIOM PROBIOTICS PRIVATE LIMITED |
Active
|
3.6 Cr | 1 | Karnataka |
| TENSHI LIFE SCIENCES PRIVATE LIMITED |
Amalgamated
|
443.2 Cr | 1 | Tamil Nadu |
| DESH SEVA SAMITI |
Active
|
0.0 | 1 | Maharashtra |
| SEQUENT SCIENTIFIC LIMITED |
Active
|
49.9 Cr | 1 | Maharashtra |
| WIPRO HEALTHCARE IT LIMITED |
Amalgamated
|
3.4 Cr | 1 | Karnataka |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Alliance Pharmacy Pty Limited | Australia | - | - |
| Altima Innvovations Inc. | United States | - | - |
| Amneal Pharma Australia Pty Ltd | Australia | - | - |
| Amneal Pharmaceuticals Pty Ltd | Australia | - | - |
| Apollo Life sciences Holding Proprietary Limited | South Africa | - | - |
| Arrow Life Sciences (Malaysia) Sdn. Bhd | Malaysia | - | - |
| Arrow Pharma (Private) Limited | Sri Lanka | - | - |
| Arrow Pharma Life Inc. | Philippines | - | - |
| Arrow Pharma Pte Limited | Singapore | - | - |
| Arrow Pharma Pty Limited | Australia | - | - |
| Arrow Pharmaceuticals Pty Limited | Australia | - | - |
| ARROW REMEDIES PRIVATE LIMITED | Maharashtra | 2015 | ₹ 1.0 L |
| Beltapharm SpA | Italy | - | - |
| CHEMSYNTH LABORATORIES PRIVATE LIMITED | Telangana | 2009 | ₹ 6.9 Cr |
| FAGRIS MEDICA PRIVATE LIMIETED | Maharashtra | 2008 | ₹ 1.0 Cr |
| Generic Partners Holding Co. Pty Limited | Australia | - | - |
| Generic Partners Pty Limited | Australia | - | - |
| Generic Partners (Canada) Inc | Canada | - | - |
| Generic Partners (International) Pte Limited | Singapore | - | - |
| Generic Partners (M) SDN BHD | Malaysia | - | - |
| Generic Partners (NZ) Limited | New Zealand | - | - |
| Generic Partners (SA) Pty Limited | South Africa | - | - |
| Generic Partners UK Limited | United Kingdom | - | - |
| Pharmacy Alliance Group Holdings Pty Limited | Australia | - | - |
| Pharmacy Alliance Investments Pty Limited | Australia | - | - |
| Pharmacy Alliance Pty Limited | Australia | - | - |
| Shasun Foundation Trust | India | - | - |
| Shasun Pharma Solutions Inc. | United States | - | - |
| Shasun USA Inc.* | United States | - | - |
| Smarterpharm Pty Limited | Australia | - | - |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED | India | - | - |
| Stabilis Pharma Inc. | United States | - | - |
| Stelis Biopharma (Malaysia) SDN. BHD. | Malaysia | - | - |
| Strides Africa Limited** | Virgin Islands, British | - | - |
| Strides Arcolab (Australia) Pty Limited | Australia | - | - |
| Strides Arcolab International Limited | United Kingdom | - | - |
| STRIDES CHEMICALS PRIVATE LIMITED | Maharashtra | 2003 | ₹ 79.7 Cr |
| Strides CIS Limited | Cyprus | - | - |
| STRIDES CONSUMER PRIVATE LIMITED | Maharashtra | 2017 | ₹ 72.7 Cr |
| STRIDES EMERGING MARKETS LIMITED | Karnataka | 2012 | ₹ 5.6 Cr |
| Strides Foundation Trust | India | - | - |
| ERIS HEALTHCARE PRIVATE LIMITED | India | - | - |
| Strides Life Sciences Limited | Nigeria | - | - |
| Strides Pharma (Cyprus) Limited | Cyprus | - | - |
| Strides Pharma (SA) Pty Limited | South Africa | - | - |
| Strides Pharma Global (UK) Limited (formerly Strides Pharma (UK) Limited) | United Kingdom | - | - |
| Strides Pharma Asia Pte Limited | Singapore | - | - |
| Strides Pharma Canada Inc | Canada | - | - |
| Strides Pharma Global Pte Limited | Singapore | - | - |
| Strides Pharma Inc. | United States | - | - |
| Strides Pharma International Limited | Cyprus | - | - |
| Strides Pharma Limited | Cyprus | - | - |
| Strides Pharma UK Limited (formerly Strides Shasun (UK) Limited) | United Kingdom | - | - |
| Strides Shasun Latina, SA de CV | Mexico | - | - |
| Strides Specialties (Holdings) Limited | Mauritius | - | - |
| Strides Vivimed Pte Ltd (formerly Vivimed Global Generics Pte Limited) | Singapore | - | - |
| SVADS Holdings SA | Switzerland | - | - |
| Trinity Pharma Proprietary Limited | South Africa | - | - |
| Universal Corporation Limited | Kenya | - | - |
| Solara Active Pharma Sciences Limited | India | - | - |
The incorporation date of STRIDES PHARMA SCIENCE LIMITED is 28 June, 1990
The authorized share capital of STRIDES PHARMA SCIENCE LIMITED is INR ₹ 218.4 Cr.
The paid-up capital of STRIDES PHARMA SCIENCE LIMITED is INR ₹ 92.0 Cr.
The registered address of STRIDES PHARMA SCIENCE LIMITED is 201, DEVAVRATA, SECTOR 17, VASHI NA NAVI MUMBAI Mumbai City Maharashtra - 400703
The CIN number of STRIDES PHARMA SCIENCE LIMITED is L24230MH1990PLC057062.
Expand
Delete
Collapse
See
details
